Prognostic score for recurrence after Whipple's pancreaticoduodenectomy for ampullary carcinomas; results of an AGEO retrospective multicenter cohort.

[1]  B. Gayet,et al.  Predictors of Long-Term Survival Following Resection for Ampullary Carcinoma: A Large Retrospective French Multicentric Study , 2014, Pancreas.

[2]  K. Lillemoe,et al.  Pancreatic Ductal Adenocarcinoma: Is There a Survival Difference for R1 Resections Versus Locally Advanced Unresectable Tumors? What Is a “True” R0 Resection? , 2013, Annals of surgery.

[3]  S. Morini,et al.  Carcinoma of the Ampulla of Vater: Morphological and Immunophenotypical Classification Predicts Overall Survival , 2013, Pancreas.

[4]  O. Clausen,et al.  Intestinal-type and Pancreatobiliary-type Adenocarcinomas: How Does Ampullary Carcinoma Differ from Other Periampullary Malignancies? , 2013, Annals of Surgical Oncology.

[5]  Jiahong Dong,et al.  [Predictors of recurrence after pancreaticoduodenectomy for carcinoma of the ampulla of Vater]. , 2012, Nan fang yi ke da xue xue bao = Journal of Southern Medical University.

[6]  M. Büchler,et al.  Effect of adjuvant chemotherapy with fluorouracil plus folinic acid or gemcitabine vs observation on survival in patients with resected periampullary adenocarcinoma: the ESPAC-3 periampullary cancer randomized trial. , 2012, JAMA.

[7]  D. Choi,et al.  Clinical significance of pathologic subtype in curatively resected ampulla of vater cancer , 2012, Journal of surgical oncology.

[8]  O. Clausen,et al.  Prognostic Relevance of Number and Ratio of Metastatic Lymph Nodes in Resected Pancreatic, Ampullary, and Distal Bile Duct Carcinomas , 2012, Annals of Surgical Oncology.

[9]  C. Willett,et al.  Carcinoma of the Ampulla of Vater: Patterns of Failure Following Resection and Benefit of Chemoradiotherapy , 2012, Annals of Surgical Oncology.

[10]  J. Cameron,et al.  Evaluation of adjuvant chemoradiation therapy for ampullary adenocarcinoma: the Johns Hopkins Hospital - Mayo Clinic collaborative study , 2011, Radiation oncology.

[11]  C. Yeo,et al.  The Influence of Prognostic Factors and Adjuvant Chemoradiation on Survival After Pancreaticoduodenectomy for Ampullary Carcinoma , 2011, Journal of Gastrointestinal Surgery.

[12]  T. Ha,et al.  Pattern Analysis of Lymph Node Metastasis and the Prognostic Importance of Number of Metastatic Nodes in Ampullary Adenocarcinoma , 2011, The American surgeon.

[13]  T. Wilson,et al.  Predicting patient survival after pancreaticoduodenectomy for malignancy: histopathological criteria based on perineural infiltration and lymphovascular invasion. , 2010, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[14]  M. Ward,et al.  Effect of Meeting Leapfrog Volume Thresholds on Complication Rates Following Complex Surgical Procedures , 2010, Annals of surgery.

[15]  M. C. Machado,et al.  Lymph Node Involvement and Not the Histophatologic Subtype Is Correlated with Outcome After Resection of Adenocarcinoma of the Ampulla of Vater , 2010, Journal of Gastrointestinal Surgery.

[16]  M. Bloomston,et al.  Predictors of Survival in Periampullary Cancers Following Pancreaticoduodenectomy , 2010, Annals of Surgical Oncology.

[17]  J. Galloway,et al.  Important Prognostic Factors in Adenocarcinoma of the Ampulla of Vater , 2009, The American surgeon.

[18]  J. Buckels,et al.  Assessment of survival advantage in ampullary carcinoma in relation to tumour biology and morphology. , 2009, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[19]  Jeffrey S. Morris,et al.  Phase II study of capecitabine and oxaliplatin for advanced adenocarcinoma of the small bowel and ampulla of Vater. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  A. Gulbinas,et al.  Tumor-related factors and patient's age influence survival after resection for ampullary adenocarcinoma. , 2008, Journal of hepato-biliary-pancreatic surgery.

[21]  H. Ohge,et al.  Prognostic Impact of Perineural Invasion Following Pancreatoduodenectomy With Lymphadenectomy for Ampullary Carcinoma , 2008, Digestive Diseases and Sciences.

[22]  K. Hatakeyama,et al.  Number of positive lymph nodes independently affects long-term survival after resection in patients with ampullary carcinoma. , 2007, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[23]  Helen Hickey,et al.  A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. , 2004, The New England journal of medicine.

[24]  C. Compton,et al.  AJCC Cancer Staging Manual , 2002, Springer New York.

[25]  D. Kerr,et al.  Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial , 2001, The Lancet.

[26]  D. Henson,et al.  Tumors of the Gallbladder, Extrahepatic Bile Ducts and Ampulla of Vater , 2000 .

[27]  F. Sellner,et al.  Implications of histological grade of tumour for the prognosis of radically resected periampullary adenocarcinoma. , 1999, The European journal of surgery = Acta chirurgica.

[28]  J. Campion,et al.  Diagnosis and Therapy for Ampullary Tumors: 63 Cases , 1996, World Journal of Surgery.

[29]  E. McFadden,et al.  Toxicity and response criteria of the Eastern Cooperative Oncology Group , 1982, American journal of clinical oncology.